1st Quarter - Report

TIBER CREEK GROUP for MERCK & CO., INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to pharmaceutical pricing.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
ANDREW MCKECHNIE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to vaccines, S. 469 Affordable and Safe Prescription Drug Importation Act, H.R. 1245 Affordable and Safe Prescription Drug Importation Act, issues related to pharmaceutical pricing, S.Amdt.134 to S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
ANDREW MCKECHNIE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 469 (115th), H.R. 1245 (115th), S.Con.Res. 3 (115th)

Pharmacy PHA

Issues related to vaccines.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
ANDREW MCKECHNIE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.